Table 3

Four-month outcome (independent variable) and between-group analysis between female and male athletes

Included
(n=237)
Female
(n=139)
Male
(n=98)
P value*
K-SESpresent 6.3 (1.6; 9.7) n=1766.1 (1.6; 9.1) n=1107.1 (2.1; 9.7) n=660.0002
K-SESfuture 7.8 (0.0; 10.0) n=1767.8 (3.0; 10.0) n=1108.0 (0.0; 10.0) n=660.084
KOOS4 63.4 (13.2) n=17661.3 (13.2) n=11066.8 (12.4) n=660.011
LSI knee extensor (%)82.5 (15.5) n=16680.3 (16.1) n=10286.1 (13.8) n=640.066
LSI knee flexor (%)92.6 (14.3) n=16692.2 (14.2) n=10293.3 (14.4) n=640.83
LSI vertical hop (%)82.6 (74.8) n=9686.3 (102.5) n=5078.7 (18.5) n=460.16
LSI hop for distance (%)82.7 (15.7) n=9078.5 (16.2) n=4486.7 (14.3) n=460.0054
LSI side hop (%)80.2 (23.3) n=6177.2 (23.6) n=2782.5 (23.2) n=340.21
  • K-SESpresent and K-SESfuture are presented as the median (min; max).

  • The KOOS4 and the results of muscle function tests are presented as the mean (SD).

  • For comparisons between groups the Mann-Whitney U test was used for continuous variables.

  • *Comparison between females and males.

  • KOOS,Knee injury and Osteoarthritis Outcome Score; K-SES, Knee Self-Efficacy Scale;LSI, Limb Symmetry Index.